These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3248763)

  • 21. [Treatment of strongyloidiasis with thiabendazole (apropos of 100 cases)].
    Domart A; Gentilini M; Thérizol M; Carbon C
    Bull Mem Soc Med Hop Paris; 1967 Oct; 118(11):1047-50. PubMed ID: 5587052
    [No Abstract]   [Full Text] [Related]  

  • 22. Strongyloidiasis at the Boston City Hospital. Emphasis on gastrointestinal pathophysiology and successful therapy with thiabendazole.
    Amir-Ahmadi H; Braun P; Neva FA; Gottlieb LS; Zamcheck N
    Am J Dig Dis; 1968 Nov; 13(11):959-73. PubMed ID: 5701918
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical and epidemiologic features of strongyloidiasis. A prospective study in rural Tennessee.
    Berk SL; Verghese A; Alvarez S; Hall K; Smith B
    Arch Intern Med; 1987 Jul; 147(7):1257-61. PubMed ID: 3606282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effectiveness and tolerance of thiabendazole in strongyloidiasis and linear dermatitis].
    Ozertskovskaia NN; Linevich OM; Karnaukhov VK
    Med Parazitol (Mosk); 1971; 40(3):346-50. PubMed ID: 5098440
    [No Abstract]   [Full Text] [Related]  

  • 25. Observations on the treatment of strongyloidiasis with thiabendazole in New York City.
    Nauenberg W; Edelman MH; Spingarn CL
    Mt Sinai J Med; 1970; 37(5):607-11. PubMed ID: 5312126
    [No Abstract]   [Full Text] [Related]  

  • 26. Strongyloidiasis after unrelated nonmyeloablative allogeneic stem cell transplantation.
    Qazilbash MH; Ueno NT; Hosing C; De Lima M; Cortes J; Massaro A; Rivera Z; Deavers M; Adachi JA; Champlin RE
    Bone Marrow Transplant; 2006 Sep; 38(5):393-4. PubMed ID: 16845427
    [No Abstract]   [Full Text] [Related]  

  • 27. Strongyloidiasis in infancy. Case report and review.
    Granot E; Deckelbaum RJ; Heldenberg D; Wagner Y; Okon E; Tamir I
    Isr J Med Sci; 1983 Dec; 19(12):1089-93. PubMed ID: 6662699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical and epidemiological characteristics of strongyloidiasis in patients with comorbidities].
    Regueira Fernandes A; Romero S; Alcântara de Souza Melo PF; Ramos Araújo PS; Bottasso O; Rocha A; Brandão E
    Rev Chilena Infectol; 2017 Feb; 34(1):47-53. PubMed ID: 28394981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strongyloidiasis in the Northern Territory. Under-recognised and under-treated?
    Fisher D; McCarry F; Currie B
    Med J Aust; 1993 Jul; 159(2):88-90. PubMed ID: 8336608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of human T-cell leukemia virus type 1 (HTLV-I) in general inhabitants in non-adult T-cell leukemia (ATL)-endemic Hokkaido, Japan.
    Kwon KW; Yano M; Sekiguchi S; Iwanaga M; Fujiwara S; Oikawa O; Sugiura M; Imai S; Osato T
    In Vivo; 1994; 8(6):1011-4. PubMed ID: 7772728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High prevalence and presumptive treatment of schistosomiasis and strongyloidiasis among African refugees.
    Posey DL; Blackburn BG; Weinberg M; Flagg EW; Ortega L; Wilson M; Secor WE; Sanders-Lewis K; Won K; Maguire JH
    Clin Infect Dis; 2007 Nov; 45(10):1310-5. PubMed ID: 17968826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Strongyloidiasis].
    Smit AM
    Ned Tijdschr Geneeskd; 1967 Jan; 111(2):74-8. PubMed ID: 6039866
    [No Abstract]   [Full Text] [Related]  

  • 33. Fatal paralytic ileus due to strongyloidiasis.
    Cookson JB; Montgomery RD; Morgan HV; Tudor RW
    Br Med J; 1972 Dec; 4(5843):771-2. PubMed ID: 4646509
    [No Abstract]   [Full Text] [Related]  

  • 34. [A case of adult T cell leukemia complicated with strongyloidiasis and amplification of pneumocystis carinii DNA in bronchoalveolar lavage fluid].
    Adachi N; Ohta K; Negoro N; Kurihara N; Takeda T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Apr; 32(4):348-52. PubMed ID: 8041045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and seroconversion to HCV in hemodialyzed patients, and epidemiological factors.
    Morales MF; Lossi JS; Alderete TN; Noli D
    Transplant Proc; 1996 Dec; 28(6):3402-5. PubMed ID: 8962329
    [No Abstract]   [Full Text] [Related]  

  • 36. [Anguillulosis. Clinical, diagnostic and therapeutic aspects. 300 cases].
    Lapierre J; Tran-Vinh-Hien
    Presse Med (1893); 1970 Oct; 78(45):1983-6. PubMed ID: 5481825
    [No Abstract]   [Full Text] [Related]  

  • 37. [Allergic syndrome in the clinical picture of strongyloidiasis].
    Tikhomirova EP; Prokhorov AF
    Med Parazitol (Mosk); 1980; 49(5):16-21. PubMed ID: 7421744
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of anguilluliasis by thiabendazole].
    Garin JP; Despeignes J; Tasseau M
    J Med Lyon; 1965 Jun; 46(78):1071-88. PubMed ID: 5888704
    [No Abstract]   [Full Text] [Related]  

  • 39. Evidence of protein-losing enteropathy in strongyloidiasis.
    Laudanna AA; Polack M; Betarello A; Kieffer J
    Rev Inst Med Trop Sao Paulo; 1973; 15(4):222-6. PubMed ID: 4755619
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of strongyloidosis with thiabendazole].
    Gentilini M; Domart A; Therizol M; Carbon C
    Presse Med (1893); 1967 Nov; 75(46):2341-2. PubMed ID: 6054154
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.